Skip to main content
Log in

Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice

  • Original Paper
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

Urinary plasminogen activator (uPA) is a serine protease that plays important roles in various extracellular proteolytic processes. In humans, protein C inhibitor (PCI) is known to regulate the activity of the serine proteases involved in blood coagulation, wound healing, and tumor metastasis, whereas PCI is not present in murine plasma or tissues other than the reproductive tissues. The large amount of uPA–PCI complexes found in human urine suggests that these complexes are formed in the kidneys. In the present study, we performed immunofluorescence double labeling and electron microscopic immunocytochemistry using renal tissues from humans and human PCI gene transgenic (PCI-TG) mice. In human renal tissues, PCI and uPA colocalized in the cytoplasm of renal proximal tubular epithelial cells (RPTECs), and juxtaposition of PCI and uPA immunoreactive particles was detected in the microvilli and lysosomes in the RPTECs. The intracellular distributions of PCI and uPA in the RPTECs from PCI-TG mice were similar to those observed in human RPTECs. These findings hint at the physiological roles of uPA and PCI in human kidneys, and also suggest that the PCI-TG mice will be useful for evaluating the roles of PCI in human physiological and pathological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

PCI:

Protein C inhibitor

uPA:

Urinary plasminogen activator

RPTECs:

Renal proximal tubular epithelial cells

References

  • Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I (2005) Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro. Reprod Biol Endocrinol 3:7

    Article  PubMed  CAS  Google Scholar 

  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1–22

    Article  PubMed  CAS  Google Scholar 

  • Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, Hamada Y, Nishioka J, Kamada H, Gabazza EC, Ido M, Uchida A, Suzuki K (2007) Protein C inhibitor inhibits breast cancer cell growth, metastasis, and angiogenesis independently of its protease inhibitory activity. Int J Cancer 121:955–965

    Article  PubMed  CAS  Google Scholar 

  • Brown PA, Wilson HM, Reid FJ, Booth NA, Simpson JG, Morrison L, Power DA, Haites NE (1994) Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int 45:43–47

    Article  PubMed  CAS  Google Scholar 

  • Cao Y, Becker C, Lundwall A, Christensson A, Gadaleanu V, Lilja H, Bjartell A (2003) Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues. Prostate 57:196–204

    Article  PubMed  CAS  Google Scholar 

  • Carlin SM, Resink TJ, Tamm M, Roth M (2005) Urokinase signal transduction and its role in cell migration. FASEB J 19:195–202

    Article  PubMed  CAS  Google Scholar 

  • Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129:307–321

    Article  PubMed  CAS  Google Scholar 

  • Conese M, Blasi F (1995) Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem Hoppe Seyler 376:143–155

    PubMed  CAS  Google Scholar 

  • Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10:39–49

    Article  PubMed  CAS  Google Scholar 

  • Eddy AA (2002) Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283:F209–F220

    PubMed  CAS  Google Scholar 

  • Espana F, Estelles A, Fernandez PJ, Gilabert J, Sanchez-Cuenca J, Griffin JH (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost 70:989–994

    PubMed  CAS  Google Scholar 

  • Florquin S, van den Berg JG, Olszyna DP, Claessen N, Opal SM, Weening JJ, van der Poll T (2001) Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int 59:2054–2061

    PubMed  CAS  Google Scholar 

  • Geiger M, Priglinger U, Griffin JH, Binder BR (1991) Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. J Biol Chem 266:11851–11857

    PubMed  CAS  Google Scholar 

  • Hayashi T, Suzuki K (1993) Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol 58:213–224

    PubMed  CAS  Google Scholar 

  • Hayashi T, Nishioka J, Kamada H, Asanuma K, Kondo H, Gabazza EC, Ido M, Suzuki K (2004) Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions. J Thromb Haemost 2:949–961

    Article  PubMed  CAS  Google Scholar 

  • Hayashi T, Nishioka J, Nakagawa N, Kamada H, Gabazza EC, Kobayashi T, Hattori A, Suzuki K (2007) Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator. J Thromb Haemost 5:1477–1485

    Article  PubMed  CAS  Google Scholar 

  • Kasza A, Petersen HH, Heegaard CW, Oka K, Christensen A, Dubin A, Chan L, Andreasen PA (1997) Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein- receptor-related protein. Eur J Biochem 248:270–281

    Article  PubMed  CAS  Google Scholar 

  • Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 89:1094–1101

    PubMed  CAS  Google Scholar 

  • List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Dano K, Behrendt N (2000) Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice. Biochemistry 39:508–515

    Article  PubMed  CAS  Google Scholar 

  • Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Menez A (2005) Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J 24:1655–1663

    Article  PubMed  CAS  Google Scholar 

  • Ma N, Ding X, Doi M, Izumi N, Semba R (2004) Cellular and subcellular localization of heme oxygenase-2 in monkey retina. J Neurocytol 33:407–415

    PubMed  Google Scholar 

  • Marksitzer R, Stief A, Menoud PA, Nagamine Y (1995) Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene. J Biol Chem 270:21833–21838

    Article  PubMed  CAS  Google Scholar 

  • Meijers JC, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN (1988) Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 27:4231–4237

    Article  PubMed  CAS  Google Scholar 

  • Moestrup SK, Nielsen S, Andreasen P, Jorgensen KE, Nykjaer A, Roigaard H, Gliemann J, Christensen EI (1993) Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem 268:16564–16570

    PubMed  CAS  Google Scholar 

  • Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25:450–455

    Article  PubMed  CAS  Google Scholar 

  • Palmieri D, Lee JW, Juliano RL, Church FC (2002) Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. J Biol Chem 277:40950–40957

    Article  PubMed  CAS  Google Scholar 

  • Petersen LC, Lund LR, Nielsen LS, Dano K, Skriver L (1988) One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263:11189–11195

    PubMed  CAS  Google Scholar 

  • Radtke KP, Fernandez JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH (1994) Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 94:2117–2124

    Article  PubMed  CAS  Google Scholar 

  • Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP (2000) Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58:1841–1850

    Article  PubMed  CAS  Google Scholar 

  • Rezaie AR, Cooper ST, Church FC, Esmon CT (1995) Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 270:25336–25339

    Article  PubMed  CAS  Google Scholar 

  • Sappino AP, Huarte J, Vassalli JD, Belin D (1991) Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962–970

    PubMed  CAS  Google Scholar 

  • Schwartz BS, Espana F (1999) Two distinct urokinase-serpin interactions regulate the initiation of cell surface-associated plasminogen activation. J Biol Chem 274:15278–15283

    Article  PubMed  CAS  Google Scholar 

  • Stief TW, Radtke KP, Heimburger N (1987) Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe Seyler 368:1427–1433

    PubMed  CAS  Google Scholar 

  • Stump DC, Thienpont M, Collen D (1986) Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma. J Biol Chem 261:12759–12766

    PubMed  CAS  Google Scholar 

  • Suzuki K (2000) Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 14:133–145

    Article  CAS  Google Scholar 

  • Suzuki K, Nishioka J, Hashimoto S (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258:163–168

    PubMed  CAS  Google Scholar 

  • Suzuki K, Nishioka J, Kusumoto H, Hashimoto S (1984) Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 95:187–195

    CAS  Google Scholar 

  • Tanski WJ, Fegley AJ, Roztocil E, Davies MG (2004) Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg 39:214–222

    Article  PubMed  Google Scholar 

  • Turner RB, Liu L, Sazonova IY, Reed GL (2002) Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem 277:33068–33074

    Article  PubMed  CAS  Google Scholar 

  • Van Leer C, Stutz M, Haeberli A, Geiser T (2005) Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. Thromb Haemost 94:1257–1264

    PubMed  Google Scholar 

  • Vassalli JD, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100:86–92

    Article  PubMed  CAS  Google Scholar 

  • Vilhardt F, Nielsen M, Sandvig K, van Deurs B (1999) Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. Mol Biol Cell 10:179–195

    PubMed  CAS  Google Scholar 

  • Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O (1996) Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol 105:53–60

    Article  PubMed  CAS  Google Scholar 

  • Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K (2004) Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 108:516–523

    Article  PubMed  CAS  Google Scholar 

  • Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T (2003) Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 44:3332–3338

    Article  PubMed  Google Scholar 

  • Zhai XY, Birn H, Jensen KB, Thomsen JS, Andreasen A, Christensen EI (2003) Digital three-dimensional reconstruction and ultrastructure of the mouse proximal tubule. J Am Soc Nephrol 14:611–619

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) (No. 17390276, 19390262), and a grant from the Mie University COE Project Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koji Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, Z., Ma, N., Hayashi, T. et al. Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice. Histochem Cell Biol 128, 293–300 (2007). https://doi.org/10.1007/s00418-007-0330-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-007-0330-6

Keywords

Navigation